curasan AG signs cooperation with INNOTERE GmbH

Kleinostheim, Germany, 7 December 2021

curasan AG signs cooperation with INNOTERE GmbH

curasan AG (Frankfurt, Germany), a pioneer and leading global provider of biomaterials for bone and tissue regeneration in dental and orthopaedic surgery, and INNOTERE GmbH (Radebeul, Germany), an undisputed leader in the field of injectable and 3D printed biomaterials, have signed a collaboration in the field of bone substitution surgery.

Under the agreement, curasan AG will significantly broaden its product portfolio starting in spring 2022.

Press contact at curasan AG
Andrea Weidner, Head of Corporate Communications
+49 6027 40 900-51;

About curasan AG
curasan develops, manufactures and markets biomaterials and medical devices in the field of bone and tissue regeneration, wound healing and osteoarthritis therapy. As a pioneer and global technology leader in the growing field of regenerative medicine, curasan is specialized primarily on biomimetic bone grafting materials for dental, oral/maxillofacial, orthopaedic and spinal applications, i.e. materials mimicking biological structures. Numerous patents and a broad record of scientific publications demonstrate the clinical success of the products and the highly innovative strength of curasan. Dental and orthopaedic clinicians worldwide benefit from the broad range of the premium quality and easy to use portfolio offered by the technology leader curasan. curasan maintains its own high-tech facilities for research, development and manufacturing of biomaterials in Frankfurt/Main, Germany. In addition to its headquarters, the company has a subsidiary, curasan, Inc., in Wake Forest, near Raleigh, N.C., USA. curasan´s innovative products are cleared by the US Food and Drug Administration (FDA) and many other international authorities and available in almost 50 countries worldwide.